🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS
What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story?
According to Dr. William Makis, this is what caught his attention.
He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly.
🔥 The story that started it
Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer.
According to Makis, Tippens received a less than 1% five year survival estimate.
He was placed on Keytruda, an immune checkpoint inhibitor.
Then came Fenbendazole.
Makis says Tippens later reported becoming cancer free and remaining so years later.
That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research.
🧬 Then Makis looked at the research
Makis says there is a growing body of preclinical research on Fenbendazole.
He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens.
According to Makis, these patients subsequently experienced major improvements after using Fenbendazole.
📈 And then the patient stories kept coming
Makis describes patients returning to him saying:
“My cancers are shrinking.”
He says some told him their oncologists were shocked by what they were seeing.
He describes reports involving:
• Stage 4 pancreatic cancer
• Cholangiocarcinoma
• Ovarian cancer
• Small cell lung cancer
He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy.
💊 The bigger conversation
This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion.
His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications.
And his final message is especially striking:
“I think repurposed drugs can give patients hope in situations that are very dire.”
That is the bigger question behind the conversation:
How many existing medicines could have unexplored potential in cancer research?
The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore.
📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion.
🔄 REPOST if you think overlooked medicines deserve more serious cancer research.
💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at
@rxmeds_store with worldwide delivery.
#Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch